Abstract
Referred to as the “single most important arrhythmia study of the 90’s”, the Multicenter Automatic Defibrillator Implantation Trial (MADIT) has had a profound effect on the worldwide practice of cardiac electrophysiology [1]. While the conclusions of the study recommend a dramatic change in therapy application for selected high-risk asymptomatic patients, the actual implementation of these recommendations has not been previously reported. We will review the MADIT experience in the United States (U.S.), placing it in historical perspective, in the first year since conclusion of the study.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M for the Multicenter Automatic Defibrillator Implantation Trial Investigators (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335: 1933–1940
MADIT Executive Committee (1991) Multicenter Automatic Defibrillator Implantation Trial (MADIT): design and clinical protocol. PACE 14 (II): 920–927
Friedman P, Stevenson W (1996) Unsustained ventricular tachycardia: to treat or not to treat. N Engl J Med 335: 1984–1985
Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou K, Moss AJ for the Multicenter Automatic Defibrillator Implantation Trial Investigators (1997) The cost effectiveness of an implanted cardiac defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: results from the economic component of the MADIT study (pre-publication draft)
Kuppermann M, Luce BR, McGovern B et al (1990) An analysis of the cost-effectiveness of the implantable defibrillator. Circulation 81: 91–100
Higgins SL (1997) The implantable cardioverter defibrillator: a videotape and Manual. Futura Publishing Co., Inc. Armonk, NY, pp 1–6
Moss AJ (1997) Update on MADIT: The Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 79 (6A): 16–17
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P for the European Myocardial Infarct Amiodarone Trial Investigators (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349: 667–674
Cairns JA, Connolly SJ, Roberts R, Gent M for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349: 675–682
Nisam S (1997) Do MADIT results apply only to “MADIT Patients”? Am J Cardiol 79 (6A): 27–30
National Heart, Lung and Blood Institute Communications (1997) NHLBI stops arrhythmia study-implantable cardiac defibrillators reduce deaths. NIH press release, April 14
Voshage-Stahl L and Capek J (1997) CPI/Guidant Corporation Marketing division (personal correspondence), March 16
Echt DS, Liebson Pr, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 324: 781–788
Parsonnet V, Escher D, Furman S et al (1984) Indications for dual-chamber pacing. PACE 7: 318–319
Viskins S, Kitzis I, Lev E, Zak Z, Heller K, Villa Y, Zajanas A, Laniado S, Belhassen B (1995) Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 25: 1327–1332
Garg R, Yusuf S (1995) Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 18: 1450–1456
Prystowsky E (1997) Management of atrial fibrillation: simplicity surrounded by controversy. Ann Intern Med 126: 244–246
Maloney JD (1989) Consequences of the Cardiac Arrhythmia Suppression Trial: calamity or clarity? Cleveland Clin J Med 56: 649–653
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia
About this chapter
Cite this chapter
Higgins, S.L., Voshage-Stahl, L. (1998). What Have We Learned from the US Experience on the Prophylactic Use of ICDs Following MADIT?. In: Raviele, A. (eds) Cardiac Arrhythmias 1997. Springer, Milano. https://doi.org/10.1007/978-88-470-2288-1_35
Download citation
DOI: https://doi.org/10.1007/978-88-470-2288-1_35
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2290-4
Online ISBN: 978-88-470-2288-1
eBook Packages: Springer Book Archive